×
Medicus Pharma Price/Book Ratio 1971-1970 | MDCX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Medicus Pharma price/book ratio from 1971 to 1970. Price/book ratio can be defined as
View More
Medicus Pharma Price/Book Ratio 1971-1970 | MDCX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Medicus Pharma price/book ratio from 1971 to 1970. Price/book ratio can be defined as
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$149.5B
Bristol Myers Squibb (BMY)
$121.6B
Vertex Pharmaceuticals (VRTX)
$119.9B
Gilead Sciences (GILD)
$117.2B
CSL (CSLLY)
$88.1B
Regeneron Pharmaceuticals (REGN)
$83.8B
GSK (GSK)
$71.1B
Argenex SE (ARGX)
$37.3B
Alnylam Pharmaceuticals (ALNY)
$32.6B
BioNTech SE (BNTX)
$28.1B
Biogen (BIIB)
$23.9B
Illumina (ILMN)
$23B
BeiGene (BGNE)
$20B
Moderna (MRNA)
$17B
Genmab (GMAB)
$14.5B
Incyte (INCY)
$14.1B
Insmed (INSM)
$13B
BioMarin Pharmaceutical (BMRN)
$12.4B
Sarepta Therapeutics (SRPT)
$12.2B
Bio-Techne Corp (TECH)
$12.1B
Exact Sciences (EXAS)
$11.4B
Vaxcyte (PCVX)
$11.4B
Exelixis (EXEL)
$10.2B
QIAGEN (QGEN)
$10B
Bio-Rad Laboratories (BIO.B)
$9.4B
Intra-Cellular Therapies (ITCI)
$9.1B
Roivant Sciences (ROIV)
$9.1B
Revolution Medicines (RVMD)
$8.7B
Repligen (RGEN)
$8.4B
Ascendis Pharma (ASND)
$8.1B